Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Re: Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancers

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad167Source: DataRank Database

Re: Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancers is a research paper published in JNCI Journal of the National Cancer Institute (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Topics (11)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Peter H. Rheinstein ORCID,Steven Lehrer ORCID

Live enrichment

PubMed:37603719 PMC:PMC10637030

National Institutes of Health

Grant: S10OD018522

National Institutes of Health

Grant: S10OD026880

Icahn School of Medicine at Mount Sinai

Office of Research Infrastructure

MeSH Terms

Cell Line, TumorHumansCarcinoma, Non-Small-Cell LungLung NeoplasmsAcrylamidesAniline CompoundsPyrimidinesIndolesProtein Kinase InhibitorsDrug Resistance, NeoplasmMutation